AI assistant
USANA HEALTH SCIENCES INC — Director's Dealing 2014
Dec 11, 2014
32704_dirs_2014-12-11_16a3c9ff-24a0-437a-83f3-0365dc2d5879.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: USANA HEALTH SCIENCES INC (USNA)
CIK: 0000896264
Period of Report: 2014-12-09
Reporting Person: WENTZ MYRON W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-09 | Common Stock | M | 95755 | $39.18 | Acquired | 6539077 | Indirect |
| 2014-12-09 | Common Stock | S | 95755 | $100.2142 | Disposed | 6443322 | Indirect |
| 2014-12-10 | Common Stock | S | 7000 | $100.7341 | Disposed | 68788 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-09 | Stock Options (right to buy) | $39.18 | M | 95755 | Disposed | 2015-12-05 | Common Stock (95755) | Direct |
Footnotes
F1: Weighted average price. Price range in multiple transactions was $100.00 to $103.00, inclusive.
F2: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz and the parent of Gull Holdings, Ltd.
F3: Held of record by Gull Holdings, Ltd., a wholly owned subsidiary of Gull Global Limited and indirectly wholly owned and controlled by Dr. Myron W. Wentz.
F4: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2014.
F5: Weighted average price. Price range in multiple transactions was $99.25 to $101.95, inclusive. The reporting person undertakes to provide USANA Health Sceinces, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth in footnotes (3) and (5).